The commercial deal adds the separation platform to Thermo Fisher's mass spectrometry lineup.
Thermo Fisher Scientific entered into a reseller agreement with Evosep to distribute the Evosep Eno separation platform globally. Evosep announced the partnership on September 28, 2026.
Under the terms of the agreement, Thermo Fisher Scientific will offer the Evosep Eno platform as part of its mass spectrometry solutions portfolio. Customers will be able to purchase the system directly through Thermo Fisher, pairing Evosep's liquid chromatography separation technology with Thermo Fisher's instruments for high-throughput proteomics workflows.
The Evosep Eno platform is designed for research, drug discovery, biomarker identification, and translational clinical studies. It aims to standardize sample preparation and analysis across laboratories to deliver reproducible data at high processing volumes.
Newsletter
Markets in your inbox, weekly
Latin America-focused analysis, investment themes and the week in finance.